Darktrace Limited

Darktrace is a global leader in cybersecurity AI, established in 2013 with a mission to free the world from cyber disruption. The company's headquarters are located in Cambridge, United Kingdom, with additional global offices in major cities such as London, San Francisco, and Singapore.

Darktrace specializes in developing and implementing AI-powered cybersecurity solutions. Its core offerings include the Enterprise Immune System, which leverages self-learning AI to detect and autonomously respond to novel cyber threats in real-time. Key products and services encompass real-time threat detection, automated threat responses via its Antigena technology, and the Cyber AI Analyst for automated incident investigation. Darktrace's technology protects diverse digital environments, including cloud, networks, IoT, industrial control systems, SaaS applications, and email platforms, serving critical infrastructure providers, public sector agencies, healthcare, financial services, and educational institutions globally.

In October 2024, Darktrace was acquired by the American private equity firm Thoma Bravo for $5.3 billion, transitioning the company from a publicly traded entity on the London Stock Exchange (LSE: DARK) to a privately held one. Ed Jennings was appointed President and CEO in March 2026, succeeding Jill Popelka. Recent developments include the introduction of Darktrace / Adaptive Human Defense and a new Managed Email Security Offering in March 2026, alongside research into evolving cyber threats, such as Chinese-nexus cyber operations and a DDoS botnet targeting gaming servers identified in early 2026.